Tinnitus, Deafness and Ear Problems Support Group
This group is for those coping with Tinnitus (ringing ears or ear noise), hearing loss, and all ear issues. Join to find support and get advice from others.
L.A. TINNITUS GROUP
MEETING REMINDER
* * * * * * * * * * * * * * * * * * * *
DATE: Saturday, September 15, 2012
TIME: 10 AM to 12 noon
PLACE: Room 206A, UCLA Medical Plaza,
200 Westwood Plaza, Westwood
DIRECTIONS To UCLA: From the 405 Freeway, exit at Wilshire Blvd East. Turn Left at Gayley Ave, and proceed to UCLA Medical Plaza Parking Entrance, North of LeConte Ave. Take ticket to enter (pay fee at designated machines before exiting). Enter building from parking area. Walk through lobby, take elevator to second floor and follow the signs to room 206A
TOPIC: Managing Tinnitus with rTMS
SPEAKER: William F. Stubbeman, MD.,
a Los Angeles based TMS Psychiatrist
Dr. Stubbeman, who specializes in brain stimulation in his psychiatry practice, will discuss rTMS (Repetitive Transcranial Magnectic Stimulation) techniques that are beneficial for individuals who experience tinnitus.
For information call Nelly Nigro 310-474-9689 OPEN DISCUSSION
MEETING REMINDER
* * * * * * * * * * * * * * * * * * * *
DATE: Saturday, September 15, 2012
TIME: 10 AM to 12 noon
PLACE: Room 206A, UCLA Medical Plaza,
200 Westwood Plaza, Westwood
DIRECTIONS To UCLA: From the 405 Freeway, exit at Wilshire Blvd East. Turn Left at Gayley Ave, and proceed to UCLA Medical Plaza Parking Entrance, North of LeConte Ave. Take ticket to enter (pay fee at designated machines before exiting). Enter building from parking area. Walk through lobby, take elevator to second floor and follow the signs to room 206A
TOPIC: Managing Tinnitus with rTMS
SPEAKER: William F. Stubbeman, MD.,
a Los Angeles based TMS Psychiatrist
Dr. Stubbeman, who specializes in brain stimulation in his psychiatry practice, will discuss rTMS (Repetitive Transcranial Magnectic Stimulation) techniques that are beneficial for individuals who experience tinnitus.
For information call Nelly Nigro 310-474-9689 OPEN DISCUSSION
All ResourcesChemicals & BioassaysBioSystemsPubChem BioAssayPubChem CompoundPubChem Structure SearchPubChem SubstanceAll Chemicals & Bioassays Resources...DNA & RNABLAST (Basic Local Alignment Search Tool)BLAST (Stand-alone)E-UtilitiesGenBankGenBank: BankItGenBank: SequinGenBank: tbl2asnGenome WorkbenchInfluenza VirusNucleotide DatabasePopSetPrimer-BLASTProSplignReference Sequence (RefSeq)RefSeqGeneSequence Read Archive (SRA)SplignTrace ArchiveUniGeneUniSTSAll DNA & RNA Resources...Data & SoftwareBLAST (Basic Local Alignment Search Tool)BLAST (Stand-alone)Cn3DConserved Domain Search Service (CD Search)E-UtilitiesGenBank: BankItGenBank: SequinGenBank: tbl2asnGenome ProtMapGenome WorkbenchPrimer-BLASTProSplignPubChem Structure SearchSNP Submission ToolSplignVector Alignment Search Tool (VAST)All Data & Software Resources...Domains & StructuresBioSystemsCn3DConserved Domain Database (CDD)Conserved Domain Search Service (CD Search)Structure (Molecular Modeling Database)Vector Alignment Search Tool (VAST)All Domains & Structures Resources...Genes & ExpressionBioSystemsDatabase of Genotypes and Phenotypes (dbGaP)E-UtilitiesGeneGene Expression Omnibus (GEO) Database Gene Expression Omnibus (GEO) DatasetsGene Expression Omnibus (GEO) ProfilesGenome WorkbenchHomoloGeneMap ViewerOnline Mendelian Inheritance in Man (OMIM)RefSeqGeneUniGeneAll Genes & Expression Resources...Genetics & MedicineBookshelfDatabase of Genotypes and Phenotypes (dbGaP)Genetic Testing RegistryInfluenza VirusMap ViewerOnline Mendelian Inheritance in Man (OMIM)PubMedPubMed Central (PMC)PubMed Clinical QueriesRefSeqGeneAll Genetics & Medicine Resources...Genomes & MapsDatabase of Genomic Structural Variation (dbVar)GenBank: tbl2asnGenomeGenome ProjectGenome ProtMapGenome WorkbenchInfluenza VirusMap ViewerNucleotide DatabasePopSetProSplignSequence Read Archive (SRA)SplignTrace ArchiveUniSTSAll Genomes & Maps Resources...HomologyBLAST (Basic Local Alignment Search Tool)BLAST (Stand-alone)BLAST Link (BLink)Conserved Domain Database (CDD)Conserved Domain Search Service (CD Search)Genome ProtMapHomoloGeneProtein ClustersAll Homology Resources...LiteratureBookshelfE-UtilitiesJournals in NCBI DatabasesMeSH DatabaseNCBI HandbookNCBI Help ManualNCBI NewsPubMedPubMed Central (PMC)PubMed Clinical QueriesAll Literature Resources...ProteinsBioSystemsBLAST (Basic Local Alignment Search Tool)BLAST (Stand-alone)BLAST Link (BLink)Conserved Domain Database (CDD)Conserved Domain Search Service (CD Search)E-UtilitiesProSplignProtein ClustersProtein DatabaseReference Sequence (RefSeq)All Proteins Resources...Sequence AnalysisBLAST (Basic Local Alignment Search Tool)BLAST (Stand-alone)BLAST Link (BLink)Conserved Domain Search Service (CD Search)Genome ProtMapGenome WorkbenchInfluenza VirusPrimer-BLASTProSplignSplignAll Sequence Analysis Resources...TaxonomyTaxonomyTaxonomy BrowserTaxonomy Common TreeAll Taxonomy Resources...Training & TutorialsNCBI Education PageNCBI HandbookNCBI Help ManualNCBI NewsScience PrimerAll Training & Tutorials Resources...VariationDatabase of Genomic Structural Variation (dbVar)Database of Genotypes and Phenotypes (dbGaP)Database of Single Nucleotide Polymorphisms (dbSNP)SNP Submission ToolAll Variation Resources...How To
All How ToChemicals & BioassaysDNA & RNAData & SoftwareDomains & StructuresGenes & ExpressionGenetics & MedicineGenomes & MapsHomologyLiteratureProteinsSequence AnalysisTaxonomyTraining & TutorialsVariationSkip to main contentSkip to navigationAbout NCBI AccesskeysMy NCBISign InSign OutPubMedUS National Library of Medicine National Institutes of Health Search termSearch databaseAll DatabasesPubMedProteinNucleotideGSSESTStructureGenomeAssemblyBioProjectBioSampleBioSystemsBooksConserved DomainsClonedbGaPdbVarEpigenomicsGeneGEO DataSetsGEO ProfilesHomoloGeneMeSHNCBI Web SiteNLM CatalogOMIAOMIMPMCPopSetProbeProtein ClustersPubChem BioAssayPubChem CompoundPubChem SubstancePubMed HealthSNPSRATaxonomyToolKitToolKitAllUniGeneUniSTSSearch
AdvancedHelp
Result FiltersDisplay Settings:AbstractFormatSummarySummary (text)AbstractAbstract (text)MEDLINEXMLPMID ListApply
Send to:Choose DestinationFileClipboardCollectionsE-mailOrderMy BibliographyCitation manager
FormatSummary (text)Abstract (text)MEDLINEXMLPMID ListCSVCreate File
1 selected item: 21975776FormatSummarySummary (text)AbstractAbstract (text)MEDLINEXMLPMID ListMeSH and Other DataE-mailSubjectAdditional textE-mail"SPAM" filtering software notice
Add to Clipboard
Add to CollectionsOrder articles
Add to My BibliographyGenerate a file for use with external citation management software.
Create File
Performing your original search, Repetitive Transcranial Magnectic Stimulation for tinnitus, in PubMed will retrieve 81 records.
Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007946.
Repetitive transcranial magnetic stimulation for tinnitus.
Meng Z, Liu S, Zheng Y, Phillips JS.
SourceDepartment of ENT, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, China, 610041.
Abstract
BACKGROUND: Tinnitus is the perception of sound, in the ear or in the head, in the absence of any external acoustic stimulation. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive means of inducing electrical currents in the brain, and has received increasing attention in recent years for the treatment of many neuropsychiatric disorders, including tinnitus.
OBJECTIVES: To assess the effectiveness and safety of rTMS versus placebo in patients with tinnitus.
SEARCH STRATEGY: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; the Cochrane Central Register of Controlled Trials (CENTRAL); PubMed; EMBASE; CINAHL; Web of Science; BIOSIS Previews; Cambridge Scientific Abstracts; ICTRP and additional sources for published and unpublished trials. The date of the most recent search was 24 May 2011.
SELECTION CRITERIA: Randomised controlled trials of rTMS versus sham rTMS.
DATA COLLECTION AND ANALYSIS: Two review authors reviewed the titles, abstracts and keywords of all records retrieved. Three review authors independently collected and extracted data, and assessed the risk of bias of the trials.
MAIN RESULTS: Five trials comprising of 233 participants met our inclusion criteria. Each study described the use of a different rTMS device that delivered different waveforms at different frequencies. All five trials were relatively small studies but generally they demonstrated a low risk of bias.When considering the impact of tinnitus on patients' quality of life, the results of only one study demonstrated a statistically significant improvement in Tinnitus Handicap Inventory (THI) scores at four months follow-up (defined as a 'partial improvement' by the study authors (THI reduction of 21% to 80%)) when low-frequency rTMS was compared with a sham control treatment. However, no statistically significant improvement was demonstrated by another two studies that considered rTMS at the same frequency. Furthermore, this single positive finding should be taken in the context of the many different variables which were recorded at many different points in time by the study authors.In accordance with our pre-specified subgroup analysis we extracted the data from one study to consider the differential effectiveness between 'lower' low-frequency rTMS (1 Hz) and 'higher' low-frequency rTMS (10 Hz, 25 Hz). In doing this we were able to demonstrate a statistically significant difference between rTMS employing a frequency of 1 Hz and the sham group when considering tinnitus severity and disability after four months follow-up ('partial' improvement). However, no statistically significant difference was demonstrated between 10 Hz and 25 Hz rTMS, and the sham control group, when considering the severity and disability of tinnitus at four months follow-up.When considering tinnitus loudness in patients undergoing rTMS we were able to demonstrate a statistically significant reduction in tinnitus loudness when the results of two studies were pooled (risk ratio 4.17, 95% confidence interval 1.30 to 13.40). However, this finding was based on two small trials and consequently the confidence interval was particularly wide.No serious adverse effects were reported in any of the trials.
AUTHORS' CONCLUSIONS: There is very limited support for the use of low-frequency rTMS for the treatment of patients with tinnitus. When considering the impact of tinnitus on patients' quality of life, support is from a single study with a low risk of bias based on a single outcome measure at a single point in time. When considering the impact on tinnitus loudness, this is based on the analysis of pooled data with a large confidence interval.Studies suggest that rTMS is a safe treatment for tinnitus in the short-term, however there were insufficient data to provide any support for the safety of this treatment in the long-term.More prospective, randomised, placebo-controlled, double-blind studies with large sample sizes are needed to confirm the effectiveness of rTMS for tinnitus patients. Uniform, validated, tinnitus-specific questionnaires and measurement scales should be used in future studies.
PMID:21975776[PubMed - indexed for MEDLINE] Publication Types, MeSH TermsPublication TypesMeta-AnalysisReviewMeSH TermsHumansQuality of LifeRandomized Controlled Trials as TopicTinnitus/therapy*Transcranial Magnetic Stimulation/instrumentationTranscranial Magnetic Stimulation/methods*
LinkOut - more resourcesFull Text SourcesJohn Wiley & Sons, Inc.EducationNew England Research Institutes Inc.MedicalTinnitus - MedlinePlus Health Information
Keynote: American Tinnitus Association
Join Dr. William Stubbeman as he speaks to the American Tinnitus Association at UCLA this Saturday, September 15th, 2012 from 10am to 12pm as he shares his recent treatment successes of tinnitus patients using rTMS.
His program is up and working, and he has all the equitment to find where your Tinnitus is, and penetrate it with the TMS.
It really is amazing. He is the only doctor in the US, that is fully operational.
The doctor is very very intelligent
Check my newest posting